MedKoo Cat#: 128760 | Name: SW106065
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SW106065 is an anticancer agent. It decreases the proliferation of S462 and SNF96.2 neurofibroma cells (EC50s = 439 and 753.6 nM).

Chemical Structure

SW106065
SW106065
CAS#62289-81-0

Theoretical Analysis

MedKoo Cat#: 128760

Name: SW106065

CAS#: 62289-81-0

Chemical Formula: C10H8N2OS

Exact Mass: 204.0357

Molecular Weight: 204.25

Elemental Analysis: C, 58.81; H, 3.95; N, 13.72; O, 7.83; S, 15.70

Price and Availability

Size Price Availability Quantity
5mg USD 350.00 2 Weeks
10mg USD 650.00 2 Weeks
25mg USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
SW106065; SW-106065; SW 106065
IUPAC/Chemical Name
N-(pyridin-3-yl)thiophene-2-carboxamide
InChi Key
UPLHUDRMLWWFRE-UHFFFAOYSA-N
InChi Code
InChI=1S/C10H8N2OS/c13-10(9-4-2-6-14-9)12-8-3-1-5-11-7-8/h1-7H,(H,12,13)
SMILES Code
O=C(NC1=CC=CN=C1)C2=CC=CS2
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 204.25 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Chau, V., Lim, S.K., Mo, W., et al. Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors. Cancer Res. 74(2), 586-597 (2014). 2. Vanderlinden, E., Marchand, A., Van Berwaer, R., et al. A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin. Antiviral Res. 196, 105208 (2021).